Purpose Biochemical control is the main determinant of survival, clinical manifestations and
comorbidities in acromegaly. Transsphenoidal selective adenomectomy (TSA) is the initial …

This review aimed to highlight the history, diagnostic criteria, preoperative prognostic factors,
surgical management, and multimodal adjuvant therapies recommended to provide a …

Background Transsphenoidal surgery (TSS) is the cornerstone of acromegaly treatment,
however there are no robust predictors of surgical outcome and remission can only be …

Background Transsphenoidal surgery is the first-choice treatment for acromegaly.
Postoperative remission is an important predictor of outcome. Various factors have been …

Simple Summary Pituitary neuroendocrine tumors (PitNET) are characterized to present a
heterogeneous behavior, and growth hormone (GH)-secreting PitNET is not an exception …

Objective To develop machine learning (ML) models that predict postoperative remission,
remission at last visit, and resistance to somatostatin receptor ligands (SRL) in patients with …

Purpose Biochemical remission (BR), gross total resection (GTR), and intraoperative
cerebrospinal fluid (CSF) leaks are important metrics in transsphenoidal surgery for …

Pituitary tumors (PT) account for 15% of intracranial tumors affect 10.7%–14.4% of the
population although the incidence of clinically relevant PT is 5.1 cases/100,000 inhabitants …

Purpose Determine predictive factors for long-term remission of acromegaly after
transsphenoidal resection of growth hormone (GH)-secreting pituitary adenomas. Methods …

Removal of tumors in the sellar and parasellar region is a well-established and highly
successful surgical method. Although surgical removal via either the transsphenoidal or the …